000 01241nam a2200349Ka 4500
001 ocn833393062
003 OCoLC
005 20221128212216.0
006 m d
007 cr cnu---unuuu
008 130329s2012 nyu o 000 0 eng d
040 _aN$T
_cN$T
020 _a9781622575473 (electronic bk.)
020 _a1622575474 (electronic bk.)
020 _z9781622575336
020 _z1622575334
035 _a(OCoLC)833393062
035 _a541991
_b(N$T)
072 7 _aMED
_x071000
_2bisacsh
049 _aN$TA
245 0 0 _aRituximab
_h[electronic resource] :
_bpharmacology, clinical uses & health effects
_c
260 _aHauppauge, N.Y. :
_bNova Science ;
_aLancaster :
_bGazelle [distributor],
_c2012.
300 _a1 online resource.
588 _aDescription based on print version record.
650 0 _aRituximab.
700 1 _aLake-Bakaar, G. V.
_q(Gerry V.),
_d1948-
856 4 0 _uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=541991
_yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938 _aEBSCOhost
_bEBSC
_n541991
910 _acpp1723AUTO
942 _n0
994 _a02
_bN$T
999 _c91098
_d91098